I greatly respect the writers -- and especially, the editor in chief (a personal friend), over at STAT+. . . and they've nicely put forward the journalistic case for why tomorrow may be a very important day, for PhRMA members, on US pharmaceutical pricing.
But -- but -- but. . . based on now three plus years of bluster and no action -- or impotent actions which plainly exceed his authority, under our founding documents -- I am pretty firmly of the view that tomorrow, or the day after, PhRMA will collectively genuflect, toward. . . 1600 Penn. . . express some earnest concern. . . and then. . . do nothing. And Trump will likewise. . . do nothing, save of course to lie about actions he's never signed, or the Congress has never passed -- as he campaigns toward November.
His base is so congenitally stupid and non-curious -- as we've long seen -- he could tell them (preposterously!) Mexico would pay for a wall (and only use that lie to bilk his followers for charity money, via Bannon), and they'd believe him -- and (stunningly, then) donate millions of dollars -- to Bannon.
So, his lying about having done nothing on US drug pricing should come as scant surprise here. I doubt anything comes of it, but here is the STAT+ ($$ subs. req.) article just the same -- do go read it all:
. . . .Drug makers and their lobbyists are struggling to agree on a strategy that would convince President Trump to back off a highly controversial drug pricing policy that he vowed to enact on Monday.
This week, the group, the Pharmaceutical Research and Manufacturers of America convened three calls with member companies to discuss how to respond to an ultimatum that Trump laid out in July. . . .
Gee -- three whole. . . calls?! I'd say there will be some polite promises, through clenched teeth, in a Boston Brahman accent. . . and. . . then poof. . . Nothing. As it has been -- since 2010. On to November -- and a change is gonna' come. . . . smile.
नमस्ते
No comments:
Post a Comment